Clinical Research Directory

Inclusion Criteria: * Provision of written informed consent; * Patients with histologically verified colon adenocarcinoma or patients with histologically verified synchronous neoplasms who have not previously received treatment for a second tumor; * Age ≥ 18 years; * Absence of antitumor treatment for a real tumor (it is allowed to include patients who have a history of antitumor treatment for other malignant tumors, if the period after treatment is more than 12 months). * The ability of the patient, according to the Researcher, to fulfill the requirements of the Protocol; Exclusion Criteria: \- Patients receiving chemotherapy or radiotherapy for colon cancer at the time of screening